Global Kidney Cancer Drug Market Research Report Forecast 2017-2021

May 2017 | 118 pages | ID: G2FEB7C6EF4EN
S&P Consulting

Abstracts

The Global Kidney Cancer Drug Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the Kidney Cancer Drug industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Kidney Cancer Drug market study provides comprehensive data which enhances the understanding, scope and application of this report.

This report provides comprehensive analysis of

• Key market segments and sub-segments
• Evolving market trends and dynamics
• Changing supply and demand scenarios
• Quantifying market opportunities through market sizing and market forecasting
• Tracking current trends/opportunities/challenges
• Competitive insights
• Opportunity mapping in terms of technological breakthroughs

Global Kidney Cancer Drug Market: Regional Segment Analysis
North America
Europe
China
Japan
Southeast Asia
India

The Major players reported in the market include:
Bayer
F. Hoffmann-La Roche
GlaxoSmithKline
Novartis
Pfizer
Abbott Laboratories
Active Biotech
Amgen
Argos Therapeutics

Global Kidney Cancer Drug Market: Product Segment Analysis
Type 1
Type 2
Type 3


Global Kidney Cancer Drug Market: Application Segment Analysis
Application 1
Application 2
Application 3

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

Contents

CHAPTER 1 KIDNEY CANCER DRUG MARKET OVERVIEW

1.1 Product Overview and Scope of Kidney Cancer Drug
1.2 Kidney Cancer Drug Market Segmentation by Type
  1.2.1 Global Production Market Share of Kidney Cancer Drug by Type in 2015
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Kidney Cancer Drug Market Segmentation by Application
  1.3.1 Kidney Cancer Drug Consumption Market Share by Application in 2015
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 Kidney Cancer Drug Market Segmentation by Regions
  1.4.1 North America
  1.4.2 China
  1.4.3 Europe
  1.4.4 Southeast Asia
  1.4.5 Japan
  1.4.6 India
1.5 Global Market Size (Value) of Kidney Cancer Drug (2012-2021)

CHAPTER 2 GLOBAL ECONOMIC IMPACT ON KIDNEY CANCER DRUG INDUSTRY

2.1 Global Macroeconomic Environment Analysis
  2.1.1 Global Macroeconomic Analysis
  2.1.2 Global Macroeconomic Environment Development Trend
2.2 Global Macroeconomic Environment Analysis by Regions

CHAPTER 3 GLOBAL KIDNEY CANCER DRUG MARKET COMPETITION BY MANUFACTURERS

3.1 Global Kidney Cancer Drug Production and Share by Manufacturers (2015 and 2016)
3.2 Global Kidney Cancer Drug Revenue and Share by Manufacturers (2015 and 2016)
3.3 Global Kidney Cancer Drug Average Price by Manufacturers (2015 and 2016)
3.4 Manufacturers Kidney Cancer Drug Manufacturing Base Distribution, Production Area and Product Type
3.5 Kidney Cancer Drug Market Competitive Situation and Trends
  3.5.1 Kidney Cancer Drug Market Concentration Rate
  3.5.2 Kidney Cancer Drug Market Share of Top 3 and Top 5 Manufacturers
  3.5.3 Mergers & Acquisitions, Expansion

CHAPTER 4 GLOBAL KIDNEY CANCER DRUG PRODUCTION, REVENUE (VALUE) BY REGION (2012-2017)

4.1 Global Kidney Cancer Drug Production by Region (2012-2017)
4.2 Global Kidney Cancer Drug Production Market Share by Region (2012-2017)
4.3 Global Kidney Cancer Drug Revenue (Value) and Market Share by Region (2012-2017)
4.4 Global Kidney Cancer Drug Production, Revenue, Price and Gross Margin (2012-2017)
4.5 North America Kidney Cancer Drug Production, Revenue, Price and Gross Margin (2012-2017)
4.6 Europe Kidney Cancer Drug Production, Revenue, Price and Gross Margin (2012-2017)
4.7 China Kidney Cancer Drug Production, Revenue, Price and Gross Margin (2012-2017)
4.8 Japan Kidney Cancer Drug Production, Revenue, Price and Gross Margin (2012-2017)
4.9 Southeast Asia Kidney Cancer Drug Production, Revenue, Price and Gross Margin (2012-2017)
4.10 India Kidney Cancer Drug Production, Revenue, Price and Gross Margin (2012-2017)

CHAPTER 5 GLOBAL KIDNEY CANCER DRUG SUPPLY (PRODUCTION), CONSUMPTION, EXPORT, IMPORT BY REGIONS (2012-2017)

5.1 Global Kidney Cancer Drug Consumption by Regions (2012-2017)
5.2 North America Kidney Cancer Drug Production, Consumption, Export, Import by Regions (2012-2017)
5.3 Europe Kidney Cancer Drug Production, Consumption, Export, Import by Regions (2012-2017)
5.4 China Kidney Cancer Drug Production, Consumption, Export, Import by Regions (2012-2017)
5.5 Japan Kidney Cancer Drug Production, Consumption, Export, Import by Regions (2012-2017)
5.6 Southeast Asia Kidney Cancer Drug Production, Consumption, Export, Import by Regions (2012-2017)
5.7 India Kidney Cancer Drug Production, Consumption, Export, Import by Regions (2012-2017)

CHAPTER 6 GLOBAL KIDNEY CANCER DRUG PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

6.1 Global Kidney Cancer Drug Production and Market Share by Type (2012-2017)
6.2 Global Kidney Cancer Drug Revenue and Market Share by Type (2012-2017)
6.3 Global Kidney Cancer Drug Price by Type (2012-2017)
6.4 Global Kidney Cancer Drug Production Growth by Type (2012-2017)

CHAPTER 7 GLOBAL KIDNEY CANCER DRUG MARKET ANALYSIS BY APPLICATION

7.1 Global Kidney Cancer Drug Consumption and Market Share by Application (2012-2017)
7.2 Global Kidney Cancer Drug Consumption Growth Rate by Application (2012-2017)
7.3 Market Drivers and Opportunities
  7.3.1 Potential Applications
  7.3.2 Emerging Markets/Countries

CHAPTER 8 GLOBAL KIDNEY CANCER DRUG MANUFACTURERS ANALYSIS

8.1 Bayer
  8.1.1 Company Basic Information, Manufacturing Base and Competitors
  8.1.2 Product Type, Application and Specification
  8.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.1.4 Business Overview
8.2 F. Hoffmann-La Roche
  8.2.1 Company Basic Information, Manufacturing Base and Competitors
  8.2.2 Product Type, Application and Specification
  8.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.2.4 Business Overview
8.3 GlaxoSmithKline
  8.3.1 Company Basic Information, Manufacturing Base and Competitors
  8.3.2 Product Type, Application and Specification
  8.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.3.4 Business Overview
8.4 Novartis
  8.4.1 Company Basic Information, Manufacturing Base and Competitors
  8.4.2 Product Type, Application and Specification
  8.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.4.4 Business Overview
8.5 Pfizer
  8.5.1 Company Basic Information, Manufacturing Base and Competitors
  8.5.2 Product Type, Application and Specification
  8.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.5.4 Business Overview
8.6 Abbott Laboratories
  8.6.1 Company Basic Information, Manufacturing Base and Competitors
  8.6.2 Product Type, Application and Specification
  8.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.6.4 Business Overview
8.7 Active Biotech
  8.7.1 Company Basic Information, Manufacturing Base and Competitors
  8.7.2 Product Type, Application and Specification
  8.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.7.4 Business Overview
8.8 Amgen
  8.8.1 Company Basic Information, Manufacturing Base and Competitors
  8.8.2 Product Type, Application and Specification
  8.8.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.8.4 Business Overview
8.9 Argos Therapeutics
  8.9.1 Company Basic Information, Manufacturing Base and Competitors
  8.9.2 Product Type, Application and Specification
  8.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.9.4 Business Overview

CHAPTER 9 KIDNEY CANCER DRUG MANUFACTURING COST ANALYSIS

9.1 Kidney Cancer Drug Key Raw Materials Analysis
  9.1.1 Key Raw Materials
  9.1.2 Price Trend of Key Raw Materials
  9.1.3 Key Suppliers of Raw Materials
  9.1.4 Market Concentration Rate of Raw Materials
9.2 Proportion of Manufacturing Cost Structure
  9.2.1 Raw Materials
  9.2.2 Labor Cost
  9.2.3 Manufacturing Expenses
9.3 Manufacturing Process Analysis of Kidney Cancer Drug

CHAPTER 10 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

10.1 Kidney Cancer Drug Industrial Chain Analysis
10.2 Upstream Raw Materials Sourcing
10.3 Raw Materials Sources of Kidney Cancer Drug Major Manufacturers in 2015
10.4 Downstream Buyers

CHAPTER 11 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

11.1 Marketing Channel
  11.1.1 Direct Marketing
  11.1.2 Indirect Marketing
  11.1.3 Marketing Channel Development Trend
11.2 Market Positioning
  11.2.1 Pricing Strategy
  11.2.2 Brand Strategy
  11.2.3 Target Client
11.3 Distributors/Traders List

CHAPTER 12 MARKET EFFECT FACTORS ANALYSIS

12.1 Technology Progress/Risk
  12.1.1 Substitutes Threat
  12.1.2 Technology Progress in Related Industry
12.2 Consumer Needs/Customer Preference Change
12.3 Economic/Political Environmental Change

CHAPTER 13 GLOBAL KIDNEY CANCER DRUG MARKET FORECAST (2017-2021)

13.1 Global Kidney Cancer Drug Production, Revenue Forecast (2017-2021)
13.2 Global Kidney Cancer Drug Production, Consumption Forecast by Regions (2017-2021)
13.3 Global Kidney Cancer Drug Production Forecast by Type (2017-2021)
13.4 Global Kidney Cancer Drug Consumption Forecast by Application (2017-2021)
13.5 Kidney Cancer Drug Price Forecast (2017-2021)

CHAPTER 14 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Kidney Cancer Drug
Figure Global Production Market Share of Kidney Cancer Drug by Type in 2015
Figure Product Picture of Type I
Table Major Manufacturers of Type I
Figure Product Picture of Type II
Table Major Manufacturers of Type II
Figure Product Picture of Type III
Table Major Manufacturers of Type III
Table Kidney Cancer Drug Consumption Market Share by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Application 3 Examples
Figure North America Kidney Cancer Drug Revenue (Million USD) and Growth Rate (2012-2021)
Figure Europe Kidney Cancer Drug Revenue (Million USD) and Growth Rate (2012-2021)
Figure China Kidney Cancer Drug Revenue (Million USD) and Growth Rate (2012-2021)
Figure Japan Kidney Cancer Drug Revenue (Million USD) and Growth Rate (2012-2021)
Figure Southeast Asia Kidney Cancer Drug Revenue (Million USD) and Growth Rate (2012-2021)
Figure India Kidney Cancer Drug Revenue (Million USD) and Growth Rate (2012-2021)
Figure Global Kidney Cancer Drug Revenue (Million UDS) and Growth Rate (2012-2021)
Table Global Kidney Cancer Drug Capacity of Key Manufacturers (2015 and 2016)
Table Global Kidney Cancer Drug Capacity Market Share by Manufacturers (2015 and 2016)
Figure Global Kidney Cancer Drug Capacity of Key Manufacturers in 2015
Figure Global Kidney Cancer Drug Capacity of Key Manufacturers in 2016
Table Global Kidney Cancer Drug Production of Key Manufacturers (2015 and 2016)
Table Global Kidney Cancer Drug Production Share by Manufacturers (2015 and 2016)
Figure 2015 Kidney Cancer Drug Production Share by Manufacturers
Figure 2016 Kidney Cancer Drug Production Share by Manufacturers
Table Global Kidney Cancer Drug Revenue (Million USD) by Manufacturers (2015 and 2016)
Table Global Kidney Cancer Drug Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Kidney Cancer Drug Revenue Share by Manufacturers
Table 2016 Global Kidney Cancer Drug Revenue Share by Manufacturers
Table Global Market Kidney Cancer Drug Average Price of Key Manufacturers (2015 and 2016)
Figure Global Market Kidney Cancer Drug Average Price of Key Manufacturers in 2015
Table Manufacturers Kidney Cancer Drug Manufacturing Base Distribution and Sales Area
Table Manufacturers Kidney Cancer Drug Product Type
Figure Kidney Cancer Drug Market Share of Top 3 Manufacturers
Figure Kidney Cancer Drug Market Share of Top 5 Manufacturers
Table Global Kidney Cancer Drug Capacity by Regions (2012-2017)
Figure Global Kidney Cancer Drug Capacity Market Share by Regions (2012-2017)
Figure Global Kidney Cancer Drug Capacity Market Share by Regions (2012-2017)
Figure 2015 Global Kidney Cancer Drug Capacity Market Share by Regions
Table Global Kidney Cancer Drug Production by Regions (2012-2017)
Figure Global Kidney Cancer Drug Production and Market Share by Regions (2012-2017)
Figure Global Kidney Cancer Drug Production Market Share by Regions (2012-2017)
Figure 2015 Global Kidney Cancer Drug Production Market Share by Regions
Table Global Kidney Cancer Drug Revenue by Regions (2012-2017)
Table Global Kidney Cancer Drug Revenue Market Share by Regions (2012-2017)
Table 2015 Global Kidney Cancer Drug Revenue Market Share by Regions
Table Global Kidney Cancer Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table North America Kidney Cancer Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Europe Kidney Cancer Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table China Kidney Cancer Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Japan Kidney Cancer Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Southeast Asia Kidney Cancer Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table India Kidney Cancer Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Global Kidney Cancer Drug Consumption Market by Regions (2012-2017)
Table Global Kidney Cancer Drug Consumption Market Share by Regions (2012-2017)
Figure Global Kidney Cancer Drug Consumption Market Share by Regions (2012-2017)
Figure 2015 Global Kidney Cancer Drug Consumption Market Share by Regions
Table North America Kidney Cancer Drug Production, Consumption, Import & Export (2012-2017)
Table Europe Kidney Cancer Drug Production, Consumption, Import & Export (2012-2017)
Table China Kidney Cancer Drug Production, Consumption, Import & Export (2012-2017)
Table Japan Kidney Cancer Drug Production, Consumption, Import & Export (2012-2017)
Table Southeast Asia Kidney Cancer Drug Production, Consumption, Import & Export (2012-2017)
Table India Kidney Cancer Drug Production, Consumption, Import & Export (2012-2017)
Table Global Kidney Cancer Drug Production by Type (2012-2017)
Table Global Kidney Cancer Drug Production Share by Type (2012-2017)
Figure Production Market Share of Kidney Cancer Drug by Type (2012-2017)
Figure 2015 Production Market Share of Kidney Cancer Drug by Type
Table Global Kidney Cancer Drug Revenue by Type (2012-2017)
Table Global Kidney Cancer Drug Revenue Share by Type (2012-2017)
Figure Production Revenue Share of Kidney Cancer Drug by Type (2012-2017)
Figure 2015 Revenue Market Share of Kidney Cancer Drug by Type
Table Global Kidney Cancer Drug Price by Type (2012-2017)
Figure Global Kidney Cancer Drug Production Growth by Type (2012-2017)
Table Global Kidney Cancer Drug Consumption by Application (2012-2017)
Table Global Kidney Cancer Drug Consumption Market Share by Application (2012-2017)
Figure Global Kidney Cancer Drug Consumption Market Share by Application in 2015
Table Global Kidney Cancer Drug Consumption Growth Rate by Application (2012-2017)
Figure Global Kidney Cancer Drug Consumption Growth Rate by Application (2012-2017)
Table Bayer Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Bayer Kidney Cancer Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Bayer Kidney Cancer Drug Market Share (2012-2017)
Table F. Hoffmann-La Roche Basic Information, Manufacturing Base, Production Area and Its Competitors
Table F. Hoffmann-La Roche Kidney Cancer Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table F. Hoffmann-La Roche Kidney Cancer Drug Market Share (2012-2017)
Table GlaxoSmithKline Basic Information, Manufacturing Base, Production Area and Its Competitors
Table GlaxoSmithKline Kidney Cancer Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table GlaxoSmithKline Kidney Cancer Drug Market Share (2012-2017)
Table Novartis Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Novartis Kidney Cancer Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Novartis Kidney Cancer Drug Market Share (2012-2017)
Table Pfizer Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Pfizer Kidney Cancer Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Pfizer Kidney Cancer Drug Market Share (2012-2017)
Table Abbott Laboratories Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Abbott Laboratories Kidney Cancer Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Abbott Laboratories Kidney Cancer Drug Market Share (2012-2017)
Table Active Biotech Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Active Biotech Kidney Cancer Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Active Biotech Kidney Cancer Drug Market Share (2012-2017)
Table Amgen Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Amgen Kidney Cancer Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Amgen Kidney Cancer Drug Market Share (2012-2017)
Table Argos Therapeutics Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Argos Therapeutics Kidney Cancer Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Argos Therapeutics Kidney Cancer Drug Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Kidney Cancer Drug
Figure Manufacturing Process Analysis of Kidney Cancer Drug
Figure Kidney Cancer Drug Industrial Chain Analysis
Table Raw Materials Sources of Kidney Cancer Drug Major Manufacturers in 2015
Table Major Buyers of Kidney Cancer Drug
Table Distributors/Traders List
Figure Global Kidney Cancer Drug Production and Growth Rate Forecast (2017-2021)
Figure Global Kidney Cancer Drug Revenue and Growth Rate Forecast (2017-2021)
Table Global Kidney Cancer Drug Production Forecast by Regions (2017-2021)
Table Global Kidney Cancer Drug Consumption Forecast by Regions (2017-2021)
Table Global Kidney Cancer Drug Production Forecast by Type (2017-2021)
Table Global Kidney Cancer Drug Consumption Forecast by Application (2017-2021)

COMPANIES MENTIONED

Bayer
F. Hoffmann-La Roche
GlaxoSmithKline
Novartis
Pfizer
Abbott Laboratories
Active Biotech
Amgen
Argos Therapeutics
ArQule
AVEO Pharmaceuticals
Bionomics
Bristol-Myers Squibb
Cerulean Pharma
Exelixis
Genentech
immatics biotechnologies
Immunicum
Ono Pharmaceutical
Onyx Therapeutics
Oxford BioMedica
Prometheus Laboratories
Seattle Genetics
Taiwan Liposome
TRACON Pharmaceuticals
Wilex